Pfizer announced last Friday that they have agreed to pay $894 million to settle 3 lawsuits that alleged Celebrex and Bextra harmed patients in the U.S. and defrauded consumers. The suits claimed that Bextra and Celebrex resulted in increased risks of heart attacks and strokes. [...]
|
|||||||
 |
Based on the results of recent testing a U.S. Food and Drug Administration (FDA) expert panel has recommended that febuxostat be approved. This would make febuxostat, to be marketed as Uloric, the first gout drug to be approved in over 40 years. [...] The Arthritis Foundation recently came out with its list of the top 10 arthritis events for the year 2007. This series will focus on those events. #1: Passage of FDA Legislation on Drug Regulation and Safety The Food and Drug Administration Amendments Act of 2007 was signed into law by President Bush in September. The result of [...] |
  
|
|||||
|
Copyright © 2010 Current Arthritis News and Research - All Rights Reserved
|
|||||||
Recent Comments